Tavneos: payments to doctors
Payments that named Tavneos as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7.2M
- Providers
- 13,682
- Transactions
- 77,316
- Average per transaction
- $93
The per-transaction average — $93 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 13,682 providers the average total is $524, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Amgen | $7,167,452 | 100.0% |